DAWEX
8.2.2024 08:31:33 CET | Business Wire | Press release
Today marks the signature of Data4Industry-X, the trusted, secure, compliant and sovereign data exchange environment for the Industry sector, under the control of the industry. Initially addressing the automotive and power generation industry challenges, the solution Data4Industry-X aims at improving competitiveness and reducing the carbon footprint of major global industrial organizations with operations spread across multiple countries. Data4Industry-X will enable organizations to innovate and operate services on distributed data, coming from various factories, organizations or countries, while keeping control over the data produced locally and abroad.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240205958581/en/
The Trusted Data Exchange Solution for Industry (Credits: Dawex)
Supported by the French government’s France 2030 initiative and the European program Next Generation1, and with the endorsement of AIF (Alliance pour l’industrie du futur), Data4Industry-X relies on the technological and industrial expertise of Dawex, Schneider Electric, Valeo, CEA, and Prosyst to deliver a powerful response to support the Industry digital transformation and capitalize on the high potential of industrial data.
Contributing to the international Manufacturing-X initiative, Data4Industry-X is a trusted and secure data exchange solution, implementing the Gaia-X de facto standards and designed in compliance with the new European data regulations, such as the Data Act.
Addressing the Industry challenge of data exchange in decentralized manufacturing, Data4Industry-X will improve efficiency and productivity, accelerate data-driven innovation, boost competitiveness and minimize carbon footprint.
In a context of heavy digital transformation and industrial sovereignty, Data4Industry-X will contribute to improving Europe’s competitiveness to ultimately foster a compelling and sustainable Industry ecosystem by leveraging the full potential of broad cross-border, cross-company, cross-factory industrial data exchanges.
“The Industry sector is a strategic pillar to the European and global economy. Accelerating data exchange across trusted data spaces will definitely have a transformative impact on industrial organizations, driving innovation and responsible growth,” said Laurent Lafaye, Dawex co-CEO. “We are extremely happy to bring Dawex technology and expertise to the deployment of Data4Industry-X, and empower the Industry to foster a resilient and sustainable Industry ecosystem,” concluded Mr. Lafaye.
“Trusted data exchange is fundamental to driving collaboration, forging partnerships, and establishing new industrial models. Those new digital models are essentials for accelerating the transformation toward a more resilient, sustainable, and high-performing industrial eco-system. Schneider Electric takes pride in contributing with our industrial digital transformation expertise to develop Data4Industry-X as a flagship project of International Manufacturing-X,“ said Marc LAFONT, Innovation and Upstream Marketing VP, Industrial Automation Business Unit, Schneider Electric.
Romain Bruniaux, VP Industry, Valeo said: “Data4Industry-X is a collaborative trusted and secure data exchange solution, It offers amazing opportunities to speed up digitalization of our manufacturing process while drastically reducing our scope 1 & 2 CO2 direct and indirect emissions. With Data4Industry-X, Valeo will have the necessary data to support and direct its actions to meet our commitment to be carbon neutral by 2050.”
“Data4Industry-X capitalizes on national technologies that have already proved their worth in industry. Given the international state of the art in the field, with few operational tools known to date, Europe has a chance to take the lead in data exchange for Manufacturing,” said Alexandre Bounouh, Director CEA List, Carnot Institute.
“Collective intelligence, shared vision, teams’ symbiosis: the ingredients come together for the success of Data4Industry-X,” says Abdallah Asse, Prosyst CEO.
About Dawex
Dawex is the leader in data exchange solutions to distribute or share data products, with trust, for any business case. With the Dawex solution Data Exchange Platform, organizations create data ecosystems based on data marketplaces and data hubs that meet regulatory requirements, address traceability and security challenges. Awarded Technology Pioneer by the World Economic Forum, Dawex is the initiator of an international standardization program on “Trusted Data Transaction”. Created in 2015, Dawex is headquartered in France, expanding business operations to Europe, Asia, North America and the Middle East.
About Schneider Electric
Schneider’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On. Our mission is to be your digital partner for Sustainability and Efficiency. We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries. We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values. www.se.com
About Valeo
As a technology company and partner to all automakers and new mobility players, Valeo is innovating to make mobility cleaner, safer and smarter. Valeo enjoys technological and industrial leadership in electrification, driving assistance systems, reinvention of the interior experience and lighting everywhere. These four areas, vital to the transformation of mobility, are the Group's growth drivers. Learn more: https://www.valeo.com/en/
About CEA-List
The CEA-List, based in Paris-Saclay and Grenoble, is a CEA technology research institute dedicated to intelligent digital systems. From artificial intelligence to digital trust, its research applies to a wide range of fields, from the industry of the future to digital health, contributing to the industrial competitiveness of its partners through innovation and technology transfer. CEA-List has been a "Carnot Institute" since 2006. Learn more: https://www.cea.fr/english
About Prosyst
Prosyst develops and markets innovative solutions (hardware and software) stimming from its strong commitment in Research and Development and offers global approaches for design, setup, simulation, data collect and management, diagnosis and performance, to support its customers all along the automated systems life cycle. Prosyst addresses all sectors of activity and counts among others, clients like Stellantis, Renault, SNCF, EDF, Naval Group, … Learn more: https://www.prosyst.fr/
1Supported by the European Union - Next Generation EU “France Relance” program
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240205958581/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom